荧光染色脂滴分析与3D重建，用于肝脂肪变性评估
June 2nd, 2023
在本文中，我们展示了一种优化的基于BODIPY 493 / 503荧光的方案，用于肝组织中的脂滴表征。通过使用正交投影和3D重建，荧光团可以成功区分微泡和大泡脂肪变性，并且可能代表用于肝脂肪变性评估的经典组织学方案的补充方法。
这种成像方法允许肝脂滴沉积的三维重建，并克服了经典组织学染色的主要缺点，这些缺点缩小了微观和大泡脂肪变性之间的成功区分。微泡性脂肪变性的评估是使用金标准组织学染色，由于天然脂滴的破坏和偶尔融合，两者和油红。pro-BODIPY为微泡肝脂肪变性评估的常规方案提供了一种替代方案，因为它具有正确的疏水性，可快速摄取和有效标记脂滴，不仅对环境极性不敏感，而且选择性极强。
这种成像方法与免疫化学技术相结合，具有更广泛的应用，可以同时检测其他亚细胞抗原，这些抗原可能推进脂滴的生物发生和动力学研究，为微泡和大泡肝脂肪变性奠定基础。
View the full transcript and gain access to thousands of scientific videos
概述
本研究提出了一种优化的基于BODIPY 493/503荧光的协议，用于表征肝组织中的脂质滴。该方法实现了三维重建，并能有效区分微泡性和巨泡性脂肪变性，为传统的组织学技术提供了一种互补的方法。
关键研究组成部分
科学领域
- 神经科学
- 生物学
- 组织学
背景
- 经典的组织学染色方法可能会破坏脂质滴。
- 微泡性脂肪变性的评估常常受到传统技术的限制。
- BODIPY荧光团提供了一种选择性和有效的标记方法。
- 这种成像方法允许在脂质滴研究中应用更广泛。
研究目的
- 优化基于荧光的脂质滴表征协议。
- 改进肝脂肪变性类型之间的区分。
- 增强脂质滴生物合成和动力学的研究。
使用的方法
- 使用BODIPY 493/503荧光团进行成像。
- 脂质滴沉积的三维重建。
- 与免疫化学技术结合以同时检测。
- 准备冷冻肝组织切片以进行分析。
主要结果
- 成功区分微泡性和巨泡性脂肪变性。
- 克服了传统组织学染色方法的局限性。
- 证明了BODIPY在标记脂质滴方面的有效性。
- 在脂质研究中具有更广泛的应用潜力。
结论
- 基于BODIPY的协议是传统方法的可行替代方案。
- 这种方法增强了肝脂肪变性的评估。
- 为研究脂质滴动力学开辟了新的途径。
常见问题
Executive Industry Relevance
Quantitative 3D analysis of fluorescent-stained lipid droplets in liver tissue enables precise assessment of hepatic steatosis, addressing a key challenge in metabolic disease research. This protocol enhances predictive confidence in early discovery and target validation by providing robust, reproducible measurements of lipid droplet size and distribution. The approach supports risk-adjusted portfolio decisions by enabling reliable discrimination between microvesicular and macrovesicular steatosis in preclinical models.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables quantitative interrogation of lipid metabolism pathways in disease-relevant liver tissue.
- Supports mechanistic de-risking by distinguishing microvesicular from macrovesicular steatosis.
- Improves predictive confidence for target validation in metabolic and liver disease programs.
Screening & Assay Development
- Facilitates preparation of validated tissue-based assays for compound screening.
- Delivers standardized, reproducible, and quantitative outputs for lipid droplet analysis.
- Enables scalable imaging workflows suitable for high-content screening platforms.
Translational & Preclinical Research
- Aligns preclinical model outputs with translational biomarkers of hepatic steatosis.
- Provides continuity from discovery through preclinical validation by enabling 3D tissue analysis.
- Supports risk-adjusted advancement decisions based on quantitative steatosis metrics.
Pipeline & Workflow Integration
This protocol integrates into the discovery-to-preclinical continuum, supporting both early mechanistic studies and downstream translational research in metabolic disease pipelines.
- Discovery Biology: Enables hypothesis testing and pathway clarification for lipid storage and metabolism.
- Screening: Provides assay-ready, reproducible, and quantitative imaging outputs for compound evaluation.
- Analytics: Delivers size, intensity, and area ratio measurements for robust statistical comparison across conditions.
- Translational Research: Bridges preclinical findings with clinical biomarker strategies for hepatic steatosis.
- Enterprise Reuse: Offers a reusable imaging and analysis capability for diverse metabolic and liver disease programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in hepatic steatosis models.
- Operational Value: Standardizes tissue imaging and analysis for reproducibility and scalability.
- Strategic Value: Improves go/no-go decisions and capital efficiency by providing robust quantitative endpoints.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of metabolic disease assets.
Implementation Considerations
- Requires expertise in fluorescence imaging and quantitative image analysis.
- Needs access to confocal microscopy and compatible image analysis software (e.g., CellProfiler).
- Demands cross-team standardization of tissue preparation and imaging protocols.
- Adaptation may be needed for different tissue types or animal models.
- Limitations include dependence on imaging infrastructure and potential variability in tissue sectioning.
